Nichols, who played Julian Baker on the teen show, admitted he had never finished the series for one main reason ...
Sport news, scores, fantasy games ...
The question was simple, yet perplexing. “Does anyone have a favorite chemical reaction?” Amy Novak, a Griffin Museum of Science and Industry scientist and educator, asked from the Percy Julian Middle ...
LENZ Therapeutics, Inc. (LENZ) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.67. This compares to a loss of $0.38 per share a year ago. These ...
LENZ Therapeutics, Inc. (LENZ) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
Lenz Therapeutics has earned the FDA’s go-ahead for its aceclidine eye drop to crack the large presbyopia market, where past efforts by other drug developers have mostly been unsuccessful. The ...
Julian McMahon was privately battling metastatic cancer before his death on July 2, 2025. The late Australian-American actor — famous for his roles in projects like Fantastic Four and the FBI ...
Julian, California, located one hour northeast of San Diego, is known as the "Apple Capital of Southern California." In Julian, visitors can feast on apple pie or harvest their own produce from ...
Actor Julian McMahon has passed away at 56. While he’s best known for Nip/Tuck, McMahon’s decades-long career in film and television includes performances opposite everyone from Sandra Bullock to ...
LENZ Therapeutics is a clinical-stage vision therapy company with one late-stage candidate with an upcoming FDA approval decision. Analyst firm sentiment is unanimously bullish, and the company's key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results